| __timestamp | Bausch Health Companies Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 241751000 |
| Thursday, January 1, 2015 | 582800000 | 322292000 |
| Friday, January 1, 2016 | 455000000 | 344320000 |
| Sunday, January 1, 2017 | 366000000 | 374644000 |
| Monday, January 1, 2018 | 414000000 | 414604000 |
| Tuesday, January 1, 2019 | 471000000 | 466000000 |
| Wednesday, January 1, 2020 | 452000000 | 535000000 |
| Friday, January 1, 2021 | 465000000 | 643000000 |
| Saturday, January 1, 2022 | 529000000 | 833000000 |
| Sunday, January 1, 2023 | 604000000 | 899625000 |
Cracking the code
In the competitive landscape of biopharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and Bausch Health Companies Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Ionis Pharmaceuticals has consistently increased its R&D expenses, culminating in a remarkable 272% growth by 2023. This upward trend underscores Ionis's dedication to pioneering new therapies and maintaining its competitive edge. In contrast, Bausch Health's R&D spending has shown more variability, with a notable 145% increase over the same period.
The data reveals a strategic focus on innovation, with Ionis Pharmaceuticals leading the charge in recent years. As the biopharma industry continues to evolve, these investments are likely to play a pivotal role in shaping the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Bausch Health Companies Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Bausch Health Companies Inc.
Summit Therapeutics Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Ionis Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
Alpine Immune Sciences, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Comparing Innovation Spending: Perrigo Company plc and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Vericel Corporation
Analyzing R&D Budgets: Bausch Health Companies Inc. vs HUTCHMED (China) Limited